Physician
Stoller, Glenn
Stoller, Glenn was paid $637K by Medicaid between Jan 2018 and Nov 2024, across 10 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 65% of everything it billed.
33Billing provider infoSTOLLER, GLENN
ROCKVILLE CENTRE, NY 11570
ROCKVILLE CENTRE, NY 11570
33aNPI1558366526assigned 06/16/2005
33bProvider typeOphthalmology Physician
28Total paid$637K
24GClaims8,724
24DCodes billed10
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in New York
Rank by total paid#154 of 1,085
Median peer was paid$34K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 783 | $19K | |
| 2019 | 1,259 | $44K | |
| 2020 | 1,036 | $98K | |
| 2021 | 1,336 | $120K | |
| 2022 | 1,353 | $102K | |
| 2023 | 1,588 | $158K | |
| 2024incomplete | 1,369 | $97K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 65% | 782 | 643 | $416K |
| 67028 | Intravitreal injection of a pharmacologic agent | 13% | 1,855 | 1,703 | $80K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 7.8% | 1,419 | 1,403 | $50K |
| 92235 | 5.7% | 1,079 | 1,059 | $37K | |
| 92250 | 4.6% | 1,483 | 1,471 | $29K | |
| 92134 | 3.2% | 1,862 | 1,747 | $20K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 76 | 76 | $2K |
| 92226 | <1% | 129 | 106 | $2K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 25 | 25 | $530.42 |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 14 | 12 | $509.91 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.